
Vaxon Biotech on Wednesday said it has completed the enrollments for mid-stage trials of its vaccine to treat non-small-cell lung …

Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

